Liu, Qiongling
Li, Lie’e
Ma, Wanrui
Yang, Zheng
Zhao, Rui
Liu, Caixia
Wan, Chonghua
Funding for this research was provided by:
the National Natural Science Foundation of China (71373058, 71373058)
Article History
Received: 20 September 2023
Accepted: 29 April 2024
First Online: 7 May 2024
Declarations
:
: The study protocol was approved by the Institutional Review Board (IRB) of the first affiliated hospital of Guangdong medical university (PJ2013037). The investigators explained the aims of the trial and the instrument to the patients and obtained informed consent from those patients who agreed to participate in the study and met with the inclusion criteria. A complete assurance was given that all information would be kept confidential. The right was given to the patients not to participate and to discontinue participation in the study with consideration /without penalty. The Declaration of Helsinki’s ethical guidelines were followed in the study.
: Not Applicable.
: The authors declare no competing interests.